Dual PPAR delta/gamma agonist offer therapeutic potential for Alzheimer's disease

被引：0

作者：

Ian Steinke ^{[1
]}

Meenakshi Singh ^{[1
]}

Rajesh Amin ^{[1
]}

机构：

[1] Department of Drug Discovery and Development,Auburn University

来源：

Neural Regeneration Research | 2024年 / 06期

关键词：

D O I：

暂无

中图分类号：

R749.16 [];

学科分类号：

100203 ;

摘要：

The increasing incidence of Alzheimer’s disease(AD) in the aging population, indicates the critical need for the development of novel targeted molecular therapies for ameliorating AD pathology. Moreover, clinical and preclinical evidence demonstrates that peroxisomal proliferator activating receptors(PPAR) agonists regulate energy and lipid homeostasis in models of diabetes, as well as improve spatial memory in animal models of AD(Khan et al., 2019).

引用

页码：1175 / 1176

页数：2

共 50 条

[31] A?-oligomers: A potential therapeutic target for Alzheimer?s disease
Ghosh, Sudeshna
Ali, Rafat
Verma, Sandeep
[J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2023, 239
[32] Necroptosis in Alzheimer's disease: Potential therapeutic target
Richard, Riane
Mousa, Shaker
[J]. BIOMEDICINE & PHARMACOTHERAPY, 2022, 152
[33] The therapeutic potential of the endocannabinoid system for Alzheimer's disease
Karl, Tim
Cheng, David
Garner, Brett
Arnold, Jonathon C.
[J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (04) : 407 - 420
[34] The Potential Therapeutic Effects of THC on Alzheimer's Disease
Cao, Chuanhai
Li, Yaqiong
Liu, Hui
Bai, Ge
Mayl, Jonathan
Lin, Xiaoyang
Sutherland, Kyle
Nabar, Neel
Cai, Jianfeng
[J]. JOURNAL OF ALZHEIMERS DISEASE, 2014, 42 (03) : 973 - 984
[35] Therapeutic Potential of Phytoconstituents in Management of Alzheimer's Disease
Singh, Anurag Kumar
Rai, Sachchida Nand
Maurya, Anand
Mishra, Gaurav
Awasthi, Rajendra
Shakya, Anshul
Chellappan, Dinesh Kumar
Dua, Kamal
Vamanu, Emanuel
Chaudhary, Sushil Kumar
Singh, M. P.
[J]. EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2021, 2021
[36] Diagnostic and therapeutic potential of exosomes in Alzheimer's disease
Martins, Tania Soares
Trindade, Dario
Vaz, Margarida
Campelo, Ines
Almeida, Martim
Trigo, Guilherme
da Cruz e Silva, Odete A. B.
Henriques, Ana Gabriela
[J]. JOURNAL OF NEUROCHEMISTRY, 2021, 156 (02) : 162 - 181
[37] Therapeutic potential of neurotrophic factors in Alzheimer’s Disease
Ava Nasrolahi
Fatemeh Javaherforooshzadeh
Mohsen Jafarzadeh-Gharehziaaddin
Javad Mahmoudi
Khadijeh Dizaji Asl
Zahra Shabani
[J]. Molecular Biology Reports, 2022, 49 : 2345 - 2357
[38] β-Arrestins as Potential Therapeutic Targets for Alzheimer's Disease
Jiang, Teng
Yu, Jin-Tai
Tan, Meng-Shan
Zhu, Xi-Chen
Tan, Lan
[J]. MOLECULAR NEUROBIOLOGY, 2013, 48 (03) : 812 - 818
[39] Therapeutic potential of neurotrophic factors in Alzheimer's Disease
Nasrolahi, Ava
Javaherforooshzadeh, Fatemeh
Jafarzadeh-Gharehziaaddin, Mohsen
Mahmoudi, Javad
Asl, Khadijeh Dizaji
Shabani, Zahra
[J]. MOLECULAR BIOLOGY REPORTS, 2022, 49 (03) : 2345 - 2357
[40] Phenylpropanoids and Alzheimer's disease: A potential therapeutic platform
Kolaj, Igri
Liyanage, S. Imindu
Weaver, Donald F.
[J]. NEUROCHEMISTRY INTERNATIONAL, 2018, 120 : 99 - 111

← 1 2 3 4 5 →